ON DEMAND: Developing Live Biotherapeutics to Target the Gut-Brain Axis to treat Parkinson’s
Date & Time
Friday, June 5, 2020, 9:00 AM - 5:00 PM
Imke Mulder

• The poly-pharmaceutical nature of LBPs offers new therapeutic avenues to treat multifactorial disease such as Parkinson’s Disease.

• What are the LBP candidates with complementary activities that protect against specific neurodegenerative readouts and the latest understanding of their mechanisms of action?


• What are the bacterial metabolites (including short-chain fatty acids) that influence gut-brain axis communication at multiple levels and how do they operate in molecular mechanisms?

Session Type
Virtual Session Link